Company News

  • News

    Gabapentin (CAS 60142-96-3) is an anticonvulsant and analgesic API widely used for the management of partial seizures, postherpetic neuralgia and other neuropathic pain conditions. Although structurally related to γ-aminobutyric acid (GABA), it does not bind directly to GABA receptors. Instead, gabapentin binds with high affinity to the α2δ-1 subunit of voltage-gated calcium channels, reducing calcium

    Read More


  • News

    Fulvestrant (CAS 129453-61-8) is a selective oestrogen receptor degrader (SERD) and pure oestrogen receptor antagonist used in the treatment of hormone receptor–positive (HR+), HER2-negative advanced or metastatic breast cancer. It binds competitively to the oestrogen receptor, accelerates its degradation and eliminates receptor-mediated signalling, thereby inhibiting tumour growth in ER-dependent cancers. Fulvestrant 129453-61-8 supplied by TCS

    Read More


  • News

    Fructose is a naturally occurring monosaccharide widely used in modern food and beverage formulations for its high relative sweetness and clean, sugar-like taste. As a simple reducing sugar found in fruits, honey and syrups, fructose delivers a sweetness level typically higher than sucrose, allowing formulators to achieve the same perceived sweetness with less total solids

    Read More


  • News

    Framycetin sulphate (CAS 4146-30-9) is the sulfate salt of framycetin (neomycin B), an aminoglycoside antibiotic produced by Streptomyces lavendulae. Aminoglycosides exert their antibacterial effect by binding to the 30S ribosomal subunit and disrupting protein synthesis, leading to misreading of mRNA and bactericidal activity against a range of Gram-negative and some Gram-positive bacteria. Framycetin Sulphate 4146-30-9

    Read More


  • News

    Fenofibrate (CAS 49562-28-9) is a fibric acid derivative used in the management of hypertriglyceridemia and mixed dyslipidemia. It is a prodrug that is rapidly converted in vivo to fenofibric acid, which activates peroxisome proliferator-activated receptor alpha (PPARα). Activation of PPARα enhances lipolysis and clearance of triglyceride-rich lipoproteins, while also modulating HDL and LDL fractions, leading

    Read More


Scroll to Top